EUCTR2009-015523-91-ATActive, not recruitingPhase 1
Placebo controlled study on effects of vitamin D supplementation in healthy women and men on immunological, endocrine and metabolic parameters
Medizinische Universiätsklinik Graz, Abteilung für Endokrinologie und Nuklearmedizin0 sitesStarted: November 6, 2009Last updated:
Conditions
Drugs
Trial Snapshot
- Phase
- Phase 1
- Status
- Active, not recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional clinical trial of medicinal product
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •Informed consent
- •Healthy volunteers
- •Age of at least 18 years
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
Exclusion Criteria
- •Hypercalcemia (>2,65mmol/L)
- •Nursing women
- •Any disease that requires continuous treatment with medications
- •Intake of medication as part of another clinical trial
Investigators
Similar Trials
Active, not recruiting
Not Applicable
Placebo controlled study on effects of vitamin D supplementation in type 1 diabetic subjects on immunological, endocrine and metabolic parameters: Step 2 of the Austrian Diabetes Prevention Programme (ADPP-002)To evaluate whether vitamin D supplementation in type 1 diabetic subjects significantly alters the proportion of regulatory T-cells of all circulating CD4 positive T-cells.EUCTR2010-018901-12-ATMedical University Graz, Department of Internal Medicine, Div. Endocrinology and Metabolism
Active, not recruiting
Not Applicable
A randomized placebo controlled trial of vitamin D3 supplementation to a vulnerable patientsgroup susceptible to uppertract respiratory infections.Patients with primary or secondary immunodeficiencies and/or patients who have an increased incidence of airborn infections more than 42 infectionsday /year.EUCTR2009-011758-16-SEKarolinska University Hospital Huddinge
Active, not recruiting
Phase 1
Prospective, placebo-controlled trial of vitamin D supplementation in patients with low-levels of 25-OH vitamin D to evaluate changes in markers of cardiovascular riskEUCTR2007-007474-33-ATDr. Harald Dobnig, Medizinische Univ. Klinik Graz, Abteilung für Endokrinologie und Nuklearmedizin100
Not yet recruiting
Not Applicable
Vitamin D and Type 2 Diabetes MellitusCTRI/2022/10/046633niversity College of Medical Sciences ang GTB Hospital
Completed
Phase 3
Effect of supplementation in treatment of women with cervical intraepithelial neoplasia 2 and 3IRCT201601045623N65Vice chancellor for research, Kashan University of Medical Sciences58